SB 905 Maryland Senate · 2026 Regular Session

Maryland Technology Development Corporation - Maryland Advanced Manufacturing Grant Program - Established

This bill establishes the Maryland Advanced Manufacturing Grant Program within the Maryland Technology Development Corporation to support companies specializing in regenerative medicine and other advanced manufacturing sectors. The program will provide grants that recipients can use exclusively for acquiring or renovating manufacturing space, improving infrastructure, and purchasing necessary equipment. A dedicated fund will be created to hold grant money, with interest earnings credited back to the fund rather than the state's general fund. The Corporation will work with the Maryland Stem Cell Research Commission to set eligibility criteria, application procedures, and award amounts, with the program taking effect on July 1, 2026.
Bill status signed all 5 stages cleared
Introduction
Feb 2026
Committee Review
Apr 2026
Senate Passage
Apr 2026
House of Delegates Passage
Apr 2026
Signed into Law
May 2026
Introduced Feb 6, 2026 Signed May 12, 2026
Maddy AI version diff · 1 comparison

What changed between versions

First - Maryland Technology Development Corporation - Maryland Advanced Manufacturing Grant Program - Established Third - Maryland Technology Development Corporation - Maryland Advanced Manufacturing Grant Program - Established · 3 edits
MINOR
This bill establishes a grant program to support companies specializing in regenerative medicine and advanced manufacturing. The primary changes involve updating the bill's procedural status, clarifying that the Corporation consults with the Maryland Stem Cell Research Commission only on regenerative medicine matters, and formally adding the Maryland Advanced Manufacturing Grant Program Fund to the list of special funds exempt from interest accrual to the General Fund.
Scope change
The bill's scope is expanded by formally establishing a new special fund and clarifying the specific consultation role of the Maryland Stem Cell Research Commission.
FISCAL

Added the Maryland Advanced Manufacturing Grant Program Fund to the list of special funds where interest earnings accrue to the General Fund rather than the fund itself.

REQUIREMENT

Modified the consultation requirement so the Corporation consults with the Maryland Stem Cell Research Commission only on items related to regenerative medicine, narrowing the scope of required collaboration.

TECHNICAL

Added procedural updates indicating the bill was adopted by the Senate and assigned a committee report status.

Floor votes · Senate Mar 3, 2026 · House of Delegates Apr 2, 2026

How they voted

470
Passed · 2 other
Total votes 49
Mar 3, 2026
D Democratic36
34 Yea 2
94% Yea
R Republican13
13 Yea
100% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
17
Key actions
10
Committee
6
May 12, 2026
Signed into law
Approved by the Governor - Chapter 379
executive
Apr 13, 2026
Upper · Passed
Returned Passed
upper
Apr 13, 2026
Lower · Passed
Third Reading Passed
lower
Apr 9, 2026
Lower · Passed
Favorable Adopted Second Reading Passed
lower
Apr 9, 2026
Lower · Passed
Favorable Report by Economic Matters
lower
Apr 2, 2026
House Of Delegates · Passed
House of Delegates Vote: pass (125-12-5)
house of delegates
Mar 20, 2026
Committee
Referred Economic Matters
lower
Mar 19, 2026
Upper · Passed
Third Reading Passed
upper
Mar 18, 2026
Upper · Passed
Favorable with Amendments {
upper
Mar 18, 2026
Upper · Passed
Favorable with Amendments Report by Finance
upper
Mar 3, 2026
Senate · Passed
Senate Vote: pass (47-0-2)
senate
Feb 6, 2026
Committee
First Reading Finance
upper
3 primary · 0 co-sponsors

Sponsors